BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8026297)

  • 1. Effects of cholecystokinin antagonists on the discriminative stimulus effects of cocaine in rats and monkeys.
    Massey BW; Vanover KE; Woolverton WL
    Drug Alcohol Depend; 1994 Jan; 34(2):105-11. PubMed ID: 8026297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of cholecystokinin antagonists to modify the discriminative stimulus effects of cocaine.
    Spealman RD
    Pharmacol Biochem Behav; 1992 Oct; 43(2):613-6. PubMed ID: 1438498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CCKA receptor antagonist devazepide does not modify opioid self-administration or drug discrimination: comparison with the dopamine antagonist haloperidol.
    Higgins GA; Joharchi N; Wang Y; Corrigall WA; Sellers EM
    Brain Res; 1994 Mar; 640(1-2):246-54. PubMed ID: 8004452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Several roles of CCKA and CCKB receptor subtypes in CCK-8-induced and LiCl-induced taste aversion conditioning.
    Mosher JT; Johnson MF; Birkemo LS; Ervin GN
    Peptides; 1996; 17(3):483-8. PubMed ID: 8735976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental area.
    Meltzer LT; Christoffersen CL; Serpa KA; Razmpour A
    Synapse; 1993 Feb; 13(2):117-22. PubMed ID: 8446920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway.
    Crawley JN
    J Neurosci; 1992 Sep; 12(9):3380-91. PubMed ID: 1527584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the reinforcing and discriminative stimulus effects of cocaine in combination with (+)-AJ76 or clozapine.
    Vanover KE; Piercey MF; Woolverton WL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):780-9. PubMed ID: 8355207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCK modulates inhibitory synaptic transmission in the solitary complex through CCKB sites.
    Branchereau P; Champagnat J; Roques BP; Denavit-Saubie M
    Neuroreport; 1992 Oct; 3(10):909-12. PubMed ID: 1330059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation into the discriminative stimulus and reinforcing properties of the CCKB-receptor antagonist, L-365,260 in rats.
    Jackson A; Tattersall D; Bentley G; Rycroft W; Bourson A; Hargreaves R; Tricklebank M; Iversen S
    Neuropeptides; 1994 May; 26(5):343-53. PubMed ID: 8065550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Devazepide, a CCKA receptor antagonist, impairs the acquisition of conditioned reward and conditioned activity.
    Josselyn SA; Franco VP; Vaccarino FJ
    Psychopharmacology (Berl); 1996 Jan; 123(2):131-43. PubMed ID: 8741936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
    Boyle SJ; Tang KW; Woodruff GN; McKnight AT
    Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCH 23390-induced hypophagia is blocked by the selective CCK-A receptor antagonist devazepide, but not by the CCK-B/gastrin receptor antagonist L-365,260.
    Cooper SJ; Barber DJ
    Brain Res Bull; 1990 Apr; 24(4):631-3. PubMed ID: 2141538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. His381 of the rat CCKB receptor is essential for CCKB versus CCKA receptor antagonist selectivity.
    Jagerschmidt A; Guillaume-Rousselet N; Vikland ML; Goudreau N; Maigret B; Roques BP
    Eur J Pharmacol; 1996 Jan; 296(1):97-106. PubMed ID: 8720482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of cocaine's discriminative stimulus effects by dopamine D(1) agonists in rhesus monkeys.
    Sinnott RS; Nader MA
    Pharmacol Biochem Behav; 2001 Feb; 68(2):301-9. PubMed ID: 11267635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor mediation of the stimulus properties of cholecystokinin.
    Melton PM; Riley AL
    Pharmacol Biochem Behav; 1994 May; 48(1):275-9. PubMed ID: 8029299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivation of cocaine conditioned place preference induced by stress is reversed by cholecystokinin-B receptors antagonist in rats.
    Lu L; Zhang B; Liu Z; Zhang Z
    Brain Res; 2002 Nov; 954(1):132-40. PubMed ID: 12393241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys.
    Kleven MS; Anthony EW; Woolverton WL
    J Pharmacol Exp Ther; 1990 Jul; 254(1):312-7. PubMed ID: 2195158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual differences in the feeding response to CCKB antagonists: role of the nucleus accumbens.
    Sills TL; Vaccarino FJ
    Peptides; 1996; 17(4):593-9. PubMed ID: 8804067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin A receptor antagonist inhibits feed memory in Japanese quail.
    Berthelot V; Belzung C; Meunier-Salaun MC; Nowak R; Picard M
    Physiol Behav; 1996 Aug; 60(2):575-9. PubMed ID: 8840921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the putative dopamine D3 receptor agonist 7-OH-DPAT in rhesus monkeys trained to discriminate cocaine from saline.
    Lamas X; Negus SS; Nader MA; Mello NK
    Psychopharmacology (Berl); 1996 Apr; 124(4):306-14. PubMed ID: 8739545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.